TJX
42
5
AES
39
-2
MMM
47
2
UA
51
-5
UHS
60
4
YUM
33
-2
FITB
36
-3
PAYX
44
6
ACN
56
2
PBI
35
2
NOV
49
-6
COST
54
4
DLTR
44
-6
CME
52
2
PCG
58
-8
ALL
43
6
AMP
52
6
TAP
43
2
STT
59
14
MAT
58
9
TJX
42
5
AES
39
-2
MMM
47
2
UA
51
-5
UHS
60
4
YUM
33
-2
FITB
36
-3
PAYX
44
6
ACN
56
2
PBI
35
2
NOV
49
-6
COST
54
4
DLTR
44
-6
CME
52
2
PCG
58
-8
ALL
43
6
AMP
52
6
TAP
43
2
STT
59
14
MAT
58
9
Financhill
Back

Stoke Therapeutics Stock Predictions

Unlock the power of "two-minute trades"

Learn how today!
Sell
1

STOK
Stoke Therapeutics

Last Price:
$9.01
Seasonality Move:
15.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free

Stoke Therapeutics Stock Forecast

  • Over the next 52 weeks, Stoke Therapeutics has on average historically risen by 12.5% based on the past 5 years of stock performance.
  • Stoke Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Stoke Therapeutics Stock Undervalued?
    The current Stoke Therapeutics [STOK] share price is $8.96. The Score for STOK is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • STOK is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Stoke Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Stoke Therapeutics has on average historically risen by 12.5% based on the past 5 years of stock performance.

Stoke Therapeutics Stock Rating

Sell
1
Stoke Therapeutics (STOK) is a Sell

Is Stoke Therapeutics overpriced?

  • Stoke Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Stoke Therapeutics Stock Price History

Is STOK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com

52-Week Data

52-Week High:
17.58
52-Week Low:
4.09

Prediction Charts

Market Cap:
474.6M
Price in USD:
8.96
Volume:
1M
Beta:
0.84

Technical Analysis

SMA50:
12.11
SMA100:
12.80
SMA200:
13.17
52-Wk Change:
68.42%

Stock Predictions

  • Is Stoke Therapeutics stock public?
    Yes, Stoke Therapeutics is a publicly traded company.
  • What is the Stoke Therapeutics stock quote today?
    The Stoke Therapeutics stock price is 8.96 USD today.
  • How to buy Stoke Therapeutics stock online?
    You can buy Stoke Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 12.04 11.11 12.14 10.82
Dec-19 11.21 11.30 11.34 10.61
Dec-20 10.81 11.68 11.84 10.81
Dec-23 11.58 11.61 11.79 11.35
Dec-24 11.35 11.32 11.61 11.10
Dec-26 11.22 11.24 11.47 11.02
Dec-27 11.12 11.06 11.54 10.91
Dec-30 10.86 10.80 11.09 10.53
Dec-31 10.96 11.03 11.09 10.77
Jan-2 11.13 11.27 11.68 10.99
Jan-3 11.18 11.49 11.73 11.18
Jan-6 11.51 11.02 11.63 10.98
Jan-7 9.82 9.31 10.56 8.88
Jan-8 9.54 8.96 9.54 8.76

Stoke Therapeutics Earnings

Stoke Therapeutics Earnings Report: Per Share Stoke Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Stoke Therapeutics Forecast Revenue Growth

Stoke Therapeutics Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.01 per share.

* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.